Don't Jump to Ubrelvy or Reyvow for Acute Migraine Treatment

You'll see new oral meds to treat acute migraine in adults, Ubrelvy (yoo-BREL-vee, ubrogepant) and Reyvow (RAY-vow, lasmiditan).

Ubrelvy is the first "gepant." It blocks receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.

It's different than the injectables for PREVENTION (Aimovig, Ajovy, Emgality)...monoclonal antibodies that block CGRP effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote